| RBNTX | TVITX | RBNTX / TVITX | |
| Total Expense Ratio | 1.48 | 0.35 | 423% |
| Annual Report Gross Expense Ratio | 1.48 | 0.43 | 344% |
| Fund Existence | 11 years | 12 years | - |
| Gain YTD | 10.853 | 10.719 | 101% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 21.1B | 3.61B | 585% |
| Annual Yield % from dividends | 0.00 | 1.91 | - |
| Returns for 1 year | 14.73 | 21.64 | 68% |
| Returns for 3 years | 50.11 | 64.10 | 78% |
| Returns for 5 years | 28.71 | 56.51 | 51% |
| Returns for 10 years | 121.35 | 193.83 | 63% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VALIX | 15.96 | 0.08 | +0.50% |
| Value Line Capital Appreciation Inv | |||
| VIIIX | 595.43 | N/A | N/A |
| Vanguard Institutional Index Instl Pl | |||
| FEDAX | 22.44 | N/A | N/A |
| Fidelity Advisor Emerg Mkts Discv A | |||
| HLMRX | 19.28 | N/A | N/A |
| Harding Loevner Intl Small Coms Instl | |||
| BRXBX | 19.82 | N/A | N/A |
| MFS Blended Research Intl Eq B | |||